ReviewMetabolism: clinical and experimental2025

Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome.

Zachary A Kipp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.